Orthocell Limited (ASX:OCC)
Australia · Delayed Price · Currency is AUD 0.7100
-0.0150 (-2.07%)
Sep 11, 2026, 12:09 PM AEST
Orthocell Market Cap
Orthocell has a market cap or net worth of 197.44 million as of September 10, 2026. Its market cap has decreased by -29.99% in one year.
Market Cap
197.44M
Enterprise Value
154.46M
Revenue
11.41M
Ranking
n/a
PE Ratio
n/a
Stock Price
0.71
ChartMarket Cap Chart
Since August 12, 2014, Orthocell's market cap has increased from 29.70M to 197.44M, an increase of 564.78%. That is a compound annual growth rate of 16.97%.
| Date | Market Cap | % Change |
|---|---|---|
| Sep 10, 2026 | 197.44M | -32.93% |
| Dec 31, 2025 | 294.37M | -9.37% |
| Dec 31, 2024 | 324.80M | 297.55% |
| Dec 29, 2023 | 81.70M | 1.05% |
| Dec 30, 2022 | 80.85M | -19.58% |
| Dec 31, 2021 | 100.54M | 20.90% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Racura Oncology | 396.06M |
| Starpharma Holdings | 386.25M |
| Tetratherix | 367.01M |
| BLS Pharmaceuticals | 271.76M |
| Actinogen Medical | 219.44M |
| Nyrada | 177.91M |
| Paradigm Biopharmaceuticals | 170.77M |
| Dimerix | 156.10M |